San Francisco, CA, United States of America

Alexander Wayne Schammel

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):

Title: Alexander Wayne Schammel: Innovator in Neurological Research

Introduction

Alexander Wayne Schammel is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of neurological research, particularly through his innovative work on SARM1 inhibitors. With a total of 2 patents, Schammel is recognized for his dedication to advancing medical science.

Latest Patents

Schammel's latest patents focus on substituted pyridine derivatives as SARM1 inhibitors. These disclosures detail substituted pyridine compounds and compositions, along with associated methods that are useful for inhibiting SARM1 activity. His work aims to provide new avenues for treating or preventing neurological diseases, showcasing his commitment to addressing critical health challenges.

Career Highlights

Currently, Alexander Wayne Schammel is associated with Nura Bio, Inc., where he continues to push the boundaries of neurological research. His expertise and innovative mindset have positioned him as a key player in the development of therapeutic solutions.

Collaborations

Throughout his career, Schammel has collaborated with talented individuals such as Jennifer Aiden Kozak and Sean Pomeroy Brown. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

In summary, Alexander Wayne Schammel is a distinguished inventor whose work on SARM1 inhibitors is paving the way for advancements in the treatment of neurological diseases. His contributions to the field are invaluable and reflect his passion for innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…